let's hope we see some shareholder support for this offer... science is moving in the right direction and funding is critical as you highlight
it's a no brainer to, at a minumum, sell on market and take up the entitlement...clocks ticking as you also point out
most interetsed in the take up of the below shareholders:
Ann: Positive in vitro data for CHM 1301 CAR NK cells, page-46
Add to My Watchlist
What is My Watchlist?